EBAC
Closed
European Biotech Acquisition Corp
11.27
+0.08 (+0.71%)
Last Update: 03 Mar 2023 00:00:00
Yesterday: 11.19
Day's Range: 0. - 0.
Send
sign up or login to leave a comment!
When Written:
11.27
European Biotech Acquisition Corp is a special purpose acquisition company (SPAC) that was formed in 2021 with the aim of acquiring one or more companies in the biotechnology sector in Europe. The company is led by a team of experienced biotech professionals and investors, including CEO Dr. Anders Hinsby, who has over 25 years of experience in the biotech industry.
The company raised $100 million in its initial public offering (IPO) in March 2021, with the intention of using the funds to identify and acquire a target company in the biotech sector. European Biotech Acquisition Corp is listed on the Nasdaq stock exchange under the ticker symbol EBACU.
As a SPAC, European Biotech Acquisition Corp has a limited lifespan and must acquire a target company within a specified timeframe or return the funds to its investors. Once a target company is acquired, the SPAC will be merged with the target company, allowing it to become publicly traded without going through the traditional IPO process.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
The company raised $100 million in its initial public offering (IPO) in March 2021, with the intention of using the funds to identify and acquire a target company in the biotech sector. European Biotech Acquisition Corp is listed on the Nasdaq stock exchange under the ticker symbol EBACU.
As a SPAC, European Biotech Acquisition Corp has a limited lifespan and must acquire a target company within a specified timeframe or return the funds to its investors. Once a target company is acquired, the SPAC will be merged with the target company, allowing it to become publicly traded without going through the traditional IPO process.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








